InflaRx NV Valuation

IFRX Stock  USD 0.89  0.02  2.30%   
Today, the firm appears to be undervalued. InflaRx NV retains a regular Real Value of $3.26 per share. The prevalent price of the firm is $0.89. Our model calculates the value of InflaRx NV from evaluating the firm fundamentals such as Return On Asset of -0.41, return on equity of -0.72, and Shares Outstanding of 67.75 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting InflaRx NV's valuation include:
Price Book
1.1168
Enterprise Value
8.4 M
Enterprise Value Ebitda
0.5036
Price Sales
964.5818
Enterprise Value Revenue
112.4825
Undervalued
Today
0.89
Please note that InflaRx NV's price fluctuation is risky at this time. Calculation of the real value of InflaRx NV is based on 3 months time horizon. Increasing InflaRx NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since InflaRx NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of InflaRx Stock. However, InflaRx NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.89 Real  3.26 Target  10.43 Hype  0.9 Naive  0.93
The intrinsic value of InflaRx NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence InflaRx NV's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
3.26
Real Value
8.08
Upside
Estimating the potential upside or downside of InflaRx NV helps investors to forecast how InflaRx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of InflaRx NV more accurately as focusing exclusively on InflaRx NV's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.31-0.17-0.11
Details
Hype
Prediction
LowEstimatedHigh
0.050.905.72
Details
Naive
Forecast
LowNext ValueHigh
0.020.935.74
Details
7 Analysts
Consensus
LowTarget PriceHigh
9.4910.4311.57
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use InflaRx NV's intrinsic value based on its ongoing forecasts of InflaRx NV's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against InflaRx NV's closest peers.

InflaRx NV Cash

27.51 Million

InflaRx NV Total Value Analysis

InflaRx NV is currently projected to have valuation of 8.38 M with market capitalization of 60.61 M, debt of 805.09 K, and cash on hands of 23.68 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the InflaRx NV fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
8.38 M
60.61 M
805.09 K
23.68 M

InflaRx NV Investor Information

About 29.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.12. Some equities with similar Price to Book (P/B) outperform the market in the long run. InflaRx NV recorded a loss per share of 0.72. The entity had not issued any dividends in recent years. Based on the key indicators related to InflaRx NV's liquidity, profitability, solvency, and operating efficiency, InflaRx NV is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.

InflaRx NV Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. InflaRx NV has an asset utilization ratio of 0.22 percent. This suggests that the Company is making $0.002181 for each dollar of assets. An increasing asset utilization means that InflaRx NV is more efficient with each dollar of assets it utilizes for everyday operations.
 
Yuan Drop
 
Covid
 
Interest Hikes

InflaRx NV Profitability Analysis

Based on InflaRx NV's profitability indicators, InflaRx NV may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess InflaRx NV's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2015-12-31
Previous Quarter
-14.4 M
Current Value
-12.3 M
Quarterly Volatility
4.8 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Gross Profit is likely to rise to about (2.7 M) in 2026. Pretax Profit Margin is likely to drop to -335.47 in 2026
For InflaRx NV profitability analysis, we use financial ratios and fundamental drivers that measure the ability of InflaRx NV to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well InflaRx NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between InflaRx NV's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of InflaRx NV over time as well as its relative position and ranking within its peers.

InflaRx NV Earnings per Share Projection vs Actual

By analyzing InflaRx NV's earnings estimates, investors can diagnose different trends across InflaRx NV's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for InflaRx NV is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
InflaRx NV is projected to generate -0.1715 in earnings per share on the 31st of December 2026. InflaRx NV earnings estimates show analyst consensus about projected InflaRx NV EPS (Earning Per Share). It derives the highest and the lowest estimates based on InflaRx NV's historical volatility. Many public companies, such as InflaRx NV, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

InflaRx NV Ownership Allocation

InflaRx NV has a total of 67.75 Million outstanding shares. InflaRx NV retains 7.32 (percent) of its outstanding shares held by insiders and 28.88 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

InflaRx NV Profitability Analysis

The company reported the previous year's revenue of 165.79 K. Net Loss for the year was (46.06 M) with loss before overhead, payroll, taxes, and interest of (5.17 M).

About InflaRx NV Valuation

Our relative valuation model uses a comparative analysis of InflaRx NV. We calculate exposure to InflaRx NV's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of InflaRx NV's related companies.
Last ReportedProjected for Next Year
Gross Profit-2.8 M-2.7 M
Pretax Profit Margin(319.49)(335.47)
Operating Profit Margin(367.70)(386.08)
Net Loss(319.53)(335.50)
Gross Profit Margin(21.86)(20.77)

InflaRx NV Current Valuation Indicators

Valuation refers to the process of determining the present value of InflaRx NV and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value InflaRx we look at many different elements of the entity such as InflaRx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as InflaRx NV, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use InflaRx NV's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes InflaRx NV's worth.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.